CIBC World Market
ALLO icon

CIBC World Market’s Allogene Therapeutics ALLO Stock Holding History

CIBC World Market’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,170
Closed -$139K – 1227
2022
Q2 		$139K Sell
12,170
-960
-7% -$8.52K ﹤0.01% 1185
2022
Q1 		$120K Buy
13,130
+573
+5% +$5.97K ﹤0.01% 1243
2021
Q4 		$187K Buy
+12,557
New +$222K ﹤0.01% 1262

Other funds holding ALLO

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIBC World Market's ALLO Position: Q3 2022 in Review

CIBC World Market sold out of Allogene Therapeutics (ALLO) in Q3 2022, closing a stake of 12,170 shares — an estimated $139K sold.

CIBC World Market first reported a position in ALLO in Q4 2021 and held it in 3 quarters. The position peaked at $187K in Q4 2021. 192 funds tracked by Wall St. Rank hold ALLO as of Q3 2022.

  • CIBC World Market reported no remaining Allogene Therapeutics position as of Q3 2022 after selling out during the quarter.
  • CIBC World Market sold 12,170 Allogene Therapeutics shares in Q3 2022, an estimated $139K.
  • CIBC World Market first reported a position in Allogene Therapeutics in Q4 2021 and held it in 3 quarters.
  • CIBC World Market's Allogene Therapeutics position peaked at $187K in Q4 2021.
  • 192 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2022.

Based on CIBC World Market's 13F filing for Q3 2022, filed 10 Nov 2022.